Quality of Products and Services
Improving the Standard of Quality Management
We conduct highly effective quality audits and enhance the human resource development programs to improve quality management levels.
We possess a variety of quality training programs, including those for new employees. There are 19 quality e-learning courses available not only for domestic companies but also for overseas affiliates. Especially for the compliance, we are using audits and other initiatives as direct training opportunities as well as conducting quality lectures. Moreover, we have been implementing frontline measures to prevent quality issues on the shop floor (QRG activities) since fiscal 2010, with the aim of identifying and eliminating risks that could lead to quality issues. We are implementing these measures in our subsidiaries and affiliates.
Award for Quality Management Activity in Mitsui Chemicals Group
Since 2010, we run the Award for Quality Management Activity in the Mitsui Chemicals Group scheme each November, which is an industry-designated quality promotion month. We encourage voluntary quality management activities and award those who have achieved outstanding results across various workplaces in order to raise quality awareness and encourage the willingness to make improvements.
In fiscal 2019, we presented one General Manager’s Prize of the RC & Quality Assurance Division, four Excellence Prizes, and two Special Prizes. The General Manager’s Prize was given to Mitsui Chemical Nagoya Works in recognition of their acquisition of IATF 16949 Certification for the electrolyte solution business, as a result of united efforts by the production, sales, and laboratory organizations.
Award for Quality Management Activity in Mitsui Chemicals Group in fiscal 2019
|General Manager’s Prize of the RC & Quality Assurance Division|
|Mitsui Advanced Composites (Zhongshan) Co., Ltd. (China)|
|Shimonoseki Mitsui Chemicals, Inc.|
|TAISHO MCT LTD. Omuta Factory|
|Utsunomiya Chemical Industry Co., Ltd.
Mitsui Chemicals Agro, Inc.
|Shanghai Sinopec Mitsui Chemicals, Co., Ltd (China)|
Responding to the Voices of Customers
Whenever we receive a complaint from one of our customers regarding our products or services, Business, Manufacturing, and Logistics Divisions together with the Quality Assurance Division work in unison to identify the cause of the complaint and to take corrective action. In this manner, every effort is made to implement preventive measures across the organization as a whole.
As one such initiative, all members of the Quality Assurance Division reassess the root cause of each complaint, reconsider appropriate countermeasures, and confirm progress every week. At the same time, energies are channeled toward extracting important case studies, particularly where there is a substantial risk to customers, and where the potential exists for similar cases to arise. These case studies are then shared across the relevant departments.
Society’s interest toward the impact of chemical substances on people’s health and the environment continues to rise. Against this backdrop, chemical substance regulations are becoming increasingly stringent with growing importance placed on the higher level of management of products containing chemical substances.
Under these circumstances, the Mitsui Chemicals Group has implemented thorough chemical substance management across the entire supply chain. We have not only set up an information database in response to inquiries regarding products containing chemical substances from customers, but also established a designated department to undertake appropriate research. Through these means, we are working diligently to reply accurately to each inquiry in a timely manner.
Response to the New Business
The Mitsui Chemicals Group takes steps to ensure compliance with all applicable statutory, regulatory, and authentication requirements on an individual product application basis and conducts internal risk assessments before bringing a particular product to market. From fiscal 2015, we established a designated group to address compliance issues in connection with laws and regulations related to pharmaceutical affairs including medical instruments and authentication. With this designated group taking the lead, every effort is made to confirm the safety and efficacy of products. Steps are also taken to strictly comply with all statutory and regulatory requirements. Moreover, we look to confirm the status of statutory, regulatory, and authentication compliance through periodic inspections after products have been launched.